EU signs COVID-19 drug procurement deal with Gilead
The new contract comes as Europe battles a burgeoning COVID wave spearheaded by the Omicron offshoot, BA.5
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gilead
FDA lifts partial clinical hold on Gilead’s blood cancer drug trials
The health regulator had placed the hold on five cancer trials in January due to an imbalance in suspected and unexpected serious…
Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1…
This clinical study is the first from Merck and Gilead’s collaboration to develop potential long-acting HIV treatment options
Kite and Shoreline Biosciences enter partnership to develop novel allogeneic cell therapies
Partnership follows Kite’s investment in Shoreline’s recent Series A financing
Kite gets US FDA nod for Yescarta to treat relapsed or refractory follicular lymphoma
Yescarta is the first CAR T-Cell therapy approved for indolent follicular lymphoma
WHO cautions against use of remdesivir for hospitalised COVID-19 patients
It is authorised or approved for use as a COVID-19 treatment in more than 50 countries
Gilead gets USFDA approval for Veklury (remdesivir) to treat COVID-19
Veklury shortened time to recovery by five days in hospitalised COVID-19 patients
Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and…
They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…
Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis
Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution